PRGO
PERRIGO Co plcCompany Information
- Company Name
- PERRIGO Co plc
- CIK
- CIK0001585364
- Category
- Large accelerated filer
- Ticker: Exchange
- PRGO: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PRGO
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-12
- Last sale
- 2025-03-10
- Shares purchased (TTM)
- 26,578
- Shares sold (TTM)
- 25,398
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 149,757,229
- Shares outstanding
- 139,100,000
- Ownership
- 107.66%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 11.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 400 | 357 | 532 | 432 | 454 | 410 | 559 | 1,464 | 543 | 659 | 751 | 598 | ||||||
| Accounts Receivable Net Current | 710 | 697 | 613 | 644 | 678 | 717 | 642 | 786 | 726 | 780 | 740 | 738 | ||||||
| Inventory Net | 1,065 | 1,121 | 1,149 | 1,227 | 1,216 | 1,155 | 1,082 | 1,134 | 1,116 | 1,121 | 1,141 | 1,150 | ||||||
| Prepaid Expense And Other Assets Current | 278 | 272 | 231 | 295 | 267 | 229 | 199 | 312 | 282 | 247 | 201 | 280 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | 0 | 265 | 273 | 281 | - | 22 | 0 | 13 | 292 | - | - | - | ||||||
| Assets Current | 2,452 | 2,712 | 2,797 | 2,879 | 2,615 | 2,533 | 2,482 | 3,708 | 2,959 | 2,806 | 2,833 | 2,765 | ||||||
| Operating Lease Right Of Use Asset | - | - | 168 | - | - | - | 175 | - | - | - | 184 | - | ||||||
| Property Plant And Equipment Net | 849 | 878 | 899 | 903 | 914 | 913 | 918 | 909 | 910 | 911 | 916 | 903 | ||||||
| Finite Lived Intangible Assets Net | 2,190 | 2,259 | 2,352 | 2,400 | 2,558 | 2,457 | 2,424 | 2,655 | 2,634 | 2,870 | 2,981 | 2,941 | ||||||
| Deferred Income Tax Assets Net | 6 | 5 | 3 | 64 | 48 | 5 | 5 | 22 | 14 | 28 | 26 | 7 | ||||||
| Other Assets Noncurrent | 259 | 261 | 262 | 302 | 302 | 301 | 319 | 300 | 316 | 349 | 335 | 387 | ||||||
| Assets Noncurrent | 5,158 | 5,271 | 5,738 | 7,205 | 7,479 | 7,227 | 7,166 | 7,495 | 7,438 | 7,834 | 7,976 | 7,993 | ||||||
| Assets | 7,610 | 7,983 | 8,535 | 10,084 | 10,094 | 9,760 | 9,648 | 11,203 | 10,397 | 10,640 | 10,809 | 10,758 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 400 | 435 | 475 | 470 | 489 | 502 | 495 | 459 | 472 | 454 | 478 | 433 | ||||||
| Employee Related Liabilities Current | 153 | 154 | 112 | 123 | 122 | 120 | 123 | 138 | 125 | 114 | 127 | 109 | ||||||
| Accrued Liabilities Current | - | - | - | 363 | 328 | 254 | - | 227 | 219 | 359 | 335 | 262 | ||||||
| Other Accrued Liabilities Current | 265 | 235 | 231 | - | - | - | 239 | - | - | - | 335 | - | ||||||
| Derivative Liabilities Current | 86 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Accrued Income Taxes Current | 29 | 29 | 21 | 6 | 10 | 14 | 17 | 10 | 12 | 8 | 42 | 10 | ||||||
| Long Term Debt Current | 11 | 11 | 37 | 37 | 36 | 36 | 36 | 441 | 441 | 441 | 441 | 38 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | 0 | 29 | 27 | 37 | - | 5 | 0 | 8 | 52 | - | - | - | ||||||
| Liabilities Current | 1,055 | 998 | 1,013 | 1,145 | 1,126 | 1,074 | 1,044 | 1,451 | 1,488 | 1,555 | 1,586 | 1,008 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Debt Noncurrent | 3,283 | 3,621 | 3,604 | 3,608 | 3,616 | 3,591 | 3,582 | 4,313 | 3,617 | 3,625 | 3,633 | 4,049 | ||||||
| Deferred Income Tax Liabilities Net | 147 | 154 | 169 | 194 | 207 | 189 | 203 | 214 | 212 | 248 | 262 | 349 | ||||||
| Other Liabilities Noncurrent | 609 | 712 | 814 | 690 | 673 | 542 | 499 | 660 | 535 | 526 | 560 | 614 | ||||||
| Liabilities Noncurrent | 4,039 | 4,487 | 4,587 | 4,492 | 4,496 | 4,322 | 4,284 | 5,187 | 4,364 | 4,399 | 4,455 | 5,012 | ||||||
| Liabilities | 5,094 | 5,485 | 5,600 | 5,638 | 5,622 | 5,396 | 5,328 | 6,637 | 5,852 | 5,953 | 6,041 | 6,020 | ||||||
Controlling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 6,541 | 6,578 | 6,608 | 6,636 | 6,664 | 6,693 | 6,734 | 6,764 | 6,786 | 6,803 | 6,838 | 6,864 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -23 | -3 | 5 | 70 | 75 | -70 | -162 | 10 | -54 | -38 | 11 | -78 | ||||||
| Retained Earnings Accumulated Deficit | -4,002 | -4,076 | -3,678 | -2,259 | -2,267 | -2,259 | -2,252 | -2,208 | -2,187 | -2,078 | -2,080 | -2,048 | ||||||
| Stockholders Equity | 2,516 | 2,499 | 2,936 | 4,447 | 4,472 | 4,364 | 4,319 | 4,566 | 4,545 | 4,687 | 4,768 | 4,738 | ||||||
| Liabilities And Stockholders Equity | 7,610 | 7,983 | 8,535 | 10,084 | 10,094 | 9,760 | 9,648 | 11,203 | 10,397 | 10,640 | 10,809 | 10,758 | ||||||
Balance Sheet Related Disclosures | ||||||||||||||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Shares Issued | 139 | 138 | 138 | 138 | 138 | 137 | 137 | 137 | 136 | 136 | 136 | 136 | ||||||
| Shares Outstanding | 139 | 138 | 138 | 138 | 138 | 137 | 137 | 137 | 136 | 136 | 136 | - | ||||||
| Allowance For Doubtful Accounts Receivable | 4 | 4 | 7 | 7 | 7 | 5 | 7 | 8 | 8 | 8 | 8 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPERRIGO Co plc (PRGO) — SEC Financial Statements & Analysis
PERRIGO Co plc (PRGO) is a pharmaceutical preparations company, incorporated in L2. PERRIGO Co plc trades on NYSE as: PRGO. PERRIGO Co plc (PRGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, PERRIGO Co plc carries a market cap of $1.42B, a P/E ratio of -0.82x, a P/B ratio of 0.56x, a P/S ratio of 0.34x, an enterprise value of $4.31B, and an EV/EBITDA multiple of -3.55x. On profitability, it posts a gross margin of 33.26%, an operating margin of -37.72%, a net margin of -41.85%, a Return on Equity (ROE) of -49.65%, a Return on Assets (ROA) of -19.60%, and a Return on Invested Capital (ROIC) of -23.60%. Per share, it reports EPS of $-12.47, diluted EPS of $-12.43, free cash flow per share of $0.86, and a dividend per share of $1.15. Over the trailing year, it posted revenue growth of -4.19% year-over-year, net income growth of 2062.97% year-over-year, and EPS growth of 2048.97% year-over-year. On the balance sheet, it maintains a current ratio of 2.32x, a quick ratio of 1.05x, working capital of $1.40B, a debt-to-equity ratio of 2.02x, a debt ratio of 0.67, an interest coverage ratio of -9.58x, free cash flow of $119.30M (TTM), and net debt of $2.90B. Figures sourced from SEC EDGAR.
- Market Cap
- $1.42B
- P/E TTM
- -0.82x
- EPS TTM
- $-12.47
- P/B TTM
- 0.56x
- ROE TTM
- -49.65%
- ROA TTM
- -19.60%
- Debt To Equity
- 2.02x
- Free Cash Flow TTM
- $119.30M
- Net Revenue TTM Growth 1Y
- -4.19%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PERRIGO Co plc in?
PERRIGO Co plc (PRGO) operates in the Pharmaceutical Preparations industry.
What exchange does PRGO trade on?
PERRIGO Co plc (PRGO) trades on the NYSE.
Where is PERRIGO Co plc incorporated?
PERRIGO Co plc is incorporated in Ireland.
When was PERRIGO Co plc (PRGO)'s most recent SEC filing?
PERRIGO Co plc (PRGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is PRGO's market cap?
PERRIGO Co plc (PRGO) has a market capitalization of $1.42B as of 2026-06-30.
What is PRGO's EPS (earnings per share)?
PERRIGO Co plc (PRGO)'s trailing twelve month EPS is $-12.47 as of 2026-06-30.
What is PRGO's ROE (return on equity)?
PERRIGO Co plc (PRGO)'s trailing twelve month Return on Equity (ROE) is -49.65% as of 2026-06-30.
What is PRGO's ROA (return on assets)?
PERRIGO Co plc (PRGO)'s trailing twelve month Return on Assets (ROA) is -19.60% as of 2026-06-30.
What is PRGO's ROIC (return on invested capital)?
PERRIGO Co plc (PRGO)'s trailing twelve month Return on Invested Capital (ROIC) is -23.60% as of 2026-06-30.
What is PRGO's EV/EBITDA?
PERRIGO Co plc (PRGO)'s trailing twelve month EV/EBITDA is -3.55x as of 2026-06-30.